Daily News Archive
Daily News Subscription
US Regulators Push "Race-Day Medication" Debate
In the US, the Association Of Racing Commissioners International announced its Drug Testing Standards & Practices Committee will meet next Tuesday (July 26) “to hear opinions & testimony on use of race-day medication in racehorses”. The hearing “is designed to offer regulators a chance to ask questions they couldn’t broach” during last month’s landmark international race-day drug summit. RCI president Ed Martin commented: “Although the summit was helpful, there was limited opportunity for regulators to ask questions of the participants. It was the consensus of those present that a follow-up meeting was necessary. The central question for regulators is the extent to which the removal of this medication on those days a horse actually races would pose any significant equine health risk.” The committee will hear from Dr Tom David (chairman of the RCI Regulatory Veterinarian Committee); Dr Scott Palmer (who chairs the American Association Of Equine Practitioners Racing Committee); Dr Edward Robinson (from the Center For Integrative Toxicology at the Veterinary Medical Center at Michigan State University); & others. In addition, both the US Thoroughbred Horsemen’s Association and the National Horsemen’s Benevolent & Protective Association “have been invited to appear in person” before the committee, while “it is anticipated other groups will be invited to submit written position papers following the July 26 meeting”.